1020 Sansom Street
Thompson Building, Suite 239
Philadelphia, PA 19107
(215) 955-6844
(215) 923-6225 fax
Thompson Building, Suite 239
Philadelphia, PA 19107
(215) 955-6844
(215) 923-6225 fax
Most Recent Peer-reviewed Publications
- Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart
- Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients
- Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion.
- Differential regulation of TNF receptor 1 and receptor 2 in adiponectin expression following myocardial ischemia
- A Comparison of the Prevalence of Lead-Contaminated Imported Chinese Ceramic Dinnerware Purchased Inside Versus Outside Philadelphia's Chinatown
- The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury
- Increased susceptibility to metabolic syndrome in adult offspring of angiotensin type 1 receptor autoantibody-positive rats
- In reply
- C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart
- A Patient with a large pulmonary saddle embolus eluding both clinical gestalt and validated decision rules
- Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats
- Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection
- Response to letter regarding article, "signature MicroRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection"
- Hypoadiponectinaemia in diabetes mellitus type 2: Molecular mechanisms and clinical significance
- C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway
- Systemic adiponectin malfunction as a risk factor for cardiovascular disease
- Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms
- Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells
- Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice
- Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury